HomeNewsWorld NewsJ&J Revenue Up on Surge in Heart Procedures

J&J Revenue Up on Surge in Heart Procedures

Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share.

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer:

Copyright: © 2023 iSeekFX. All Rights Reserved.